Reduced acute nociception and chronic pain in Shank2−/− mice

• Published in: Molecular pain Vol. 12
• Main Authors: Ko, Hyoung-Gon, Oh, Seog-Bae, Zhuo, Min, Kaang, Bong-Kiun
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 2016; Sage Publications Ltd
• Subjects: Acute Disease; Analgesia; Animals; Autism; Chronic pain; Chronic Pain - metabolism; Chronic Pain - physiopathology; Cognitive ability; Male; Mental disorders; Mice, Knockout; Nerve Tissue Proteins - deficiency; Nerve Tissue Proteins - metabolism; Nociception; Pain; Pain perception; Risk factors; Short Report; Social interactions; Tactile perception; Touch Perception; Autism; nociception; pain; shank2
• ISSN: 1744-8069; 1744-8069
• DOI: 10.1177/1744806916647056

Autism spectrum disorder is a debilitating mental illness and social issue. Autism spectrum disorder patients suffer from social isolation, cognitive deficits, compulsive behavior, and sensory deficits, including hyposensitivity to pain. However, recent studies argued that autism spectrum disorder patients show physiological pain response and, in some cases, even extremely intense pain response to harmless stimulation. Recently, Shank gene family was reported as one of the genetic risk factors of autism spectrum disorder. Thus, in this study, we used Shank2− / − (Shank2 knock-out, KO) mice to investigate the controversial pain sensitivity issue and found that Shank2 KO mice showed reduced tactile perception and analgesia to chronic pain.